New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both. The animal study, in the May 13 issue of The Journal of Neuroscience, shows an important role for fibroblast growth factor 2 (FGF2), a chemical important in brain development, in anxiety.
Popularity: 1% [?]
Related posts:
- Identification Of Potential New Drug Target For Depression
- New Animal Study Of Rexahn’s Serdaxin™ Shows Drug’s Promise To Treat Anxiety And Depression With Minimal Side Effects
- Potential New Depression Treatment From Study Of Stress And Nerve Cells Survival In Rats
- New Insights Into Teenagers And Anxiety Disorders
- How Anti-Depressants Create New Brain Cells
Comments
No Responses to “Animal Study Suggests Potential New Treatment For Anxiety Disorders And Depression”